TARRAH LOWTHER: Open Payments
NPI 1326817453 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,601 in 132 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $1,626 · 2025 $2,601
Food & beverage: $2,502Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $826 |
| Janssen Biotech, Inc. | 10 | $268 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $199 |
| Phathom Pharmaceuticals, Inc. | 7 | $192 |
| Ardelyx, Inc. | 6 | $153 |
| Aimmune Therapeutics, Inc. | 8 | $151 |
| QOL Medical, LLC | 5 | $107 |
| Lilly USA, LLC | 6 | $96 |
| Madrigal Pharmaceuticals | 3 | $90 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $86 |
Products named: RINVOQ, TREMFYA, LINZESS, VOQUEZNA, ENTYVIO, IBSRELA, Sucraid, OMVOH.
Industry payments across MS — which companies pay providers there.
